Competition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1

RNA

Volumn 11, Issue 11, 2005, Pages 1725-1736

  Shukla, Supriya ^a   Del Gatto Konczak, Fabienne ^b   Breathnach, Richard ^b   Fisher, Steven A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT DE BIOLOGIE   (France)

Author keywords

Alternative splicing; Myosin phosphatase; Phenotype; Smooth muscle

Indexed keywords

MYOSIN PHOSPHATE TARGETING SUBUNIT 1 PROTEIN; PROTEIN; PTB PROTEIN; RNA BINDING PROTEIN; TIA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EXON; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; RNA SPLICING; SMOOTH MUSCLE CONTRACTILITY;

ALTERNATIVE SPLICING; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CHICKENS; EXONS; GIZZARD; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHENOTYPE; PHOSPHOPROTEIN PHOSPHATASE; POLY(A)-BINDING PROTEINS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RATS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA-BINDING PROTEINS;

EID: 27144550122     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.7176605     Document Type: Article

References (58)

1. Babij, P. and Periasamy, M. 1989. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J. Mol. Biol. 210: 673-679.
2. Beck, A.R., Medley, Q.G., O'Brien, S., Anderson, P., and Streuli, M. 1996. Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. Nucleic Acids Res. 24: 3829-3835.
3. Black, D.L. 2000. Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology. Cell 103: 367-370.
4. Buerstedde, J.M., Reynaud, C.A., Humphries, E.H., Olson, W., Ewert, D.L., and Weill, J.C. 1990. Light chain gene conversion continues at high rate in an ALV-induced cell line. EMBO J. 9: 921-927.
5. Charlet, B., Logan, P., Singh, G., and Cooper, T.A. 2002. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9: 649-658.
6. Dirksen, W.P., Vladic, F., and Fisher, S.A. 2000. A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch. Am. J. Physiol. Cell. Physiol. 278: C589-C600.
7. Dirksen, W.P., Mohamed, S.A., and Fisher, S.A. 2003. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element. J. Biol. Chem. 278: 9722-9732.
8. Elbashir, S.M., Harborth, J., Weber, K., and Tuschl, T. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213.
9. Fisher, S.A., Ikebe, M., and Brozovich, F. 1997. Endothelin-1 alters the contractile phenotype of cultured embryonic smooth muscle cells. Circ. Res. 80: 885-893.
10. Forch, P., Puig, O., Kedersha, N., Martinez, C., Granneman, S., Seraphin, B., Anderson, P., and Valcarcel, J. 2000. The apoptosispromoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol. Cell 6: 1089-1098.
11. Gatto-Konczak, F., Bourgeois, C.F., Le Guiner, C., Kister, L., Gesnel, M.C., Stevenin, J., and Breathnach, R. 2000. The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. Mol. Cell Biol. 20: 6287-6299.
12. Gooding, C., Roberts, G.C., and Smith, C.W. 1998. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon 10. RNA 4: 85-100.
13. Graham, F.L., Smiley, J., Russell, W.C., and Nairn, R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen. Virol. 36: 59-74.
14. Gromak, N., Matlin, A.J., Cooper, T.A., and Smith, C.W. 2003a. Antagonistic regulation of α-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA 9: 443-456.
15. Gromak, N., Rideau, A., Southby, J., Scadden, A.D., Gooding, C., Huttelmaier, S., Singer, R.H., and Smith, C.W. 2003b. The PTB interacting protein raver1 regulates a-tropomyosin alternative splicing. EMBO J. 22: 6356-6364.
16. Grossman, J.S., Meyer, M.I., Wang, Y.C., Mulligan, G.J., Kobayashi, R., and Helfman, D.M. 1998. The use of antibodies to the polypyrimidine tract binding protein (PTB) to analyze the protein components that assemble on alternatively spliced pre-mRNAs that use distant branch points. RNA 4: 613-625.
17. Helper, D.J., Lash, J.A., and Hathaway, D.R. 1988. Distribution of isoelectric variants of the 17,000-dalton myosin light chain in mammalian smooth muscle. J. Biol. Chem. 263: 15748-15753.
18. Ito, M., Nakano, T., Erdodi, F., and Hartshorne, D.J. 2004. Myosin phosphatase: Structure, regulation and function. Mol. Cell Biochem. 259: 197-209.
19. Johnson, D., Cohen, P., Chen, M.X., Chen, Y.H., and Cohen, P.T. 1997. Identification of the regions on the M110 subunit of protein phosphatase 1M that interact with the M21 subunit and with myosin. Eur. J. Biochem. 244: 931-939.
20. Kedersha, N.L., Gupta, M., Li, W., Miller, I., and Anderson, P. 1999. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 α to the assembly of mammalian stress granules. J. Cell. Biol. 147: 1431-1442.
21. Kedersha, N., Cho, M.R., Li, W., Yacono, P.W., Chen, S., Gilks, N., Golan, D.E., and Anderson, P. 2000. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell. Biol. 151: 1257-1268.
22. Kelley, C.A., Takahashi, M., Yu, J.H., and Adelstein, R.S. 1993. An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature. J. Biol. Chem. 268: 12848-12854.
23. Khatri, J.J., Joyce, K.M., Brozovich, F.V., and Fisher, S.A. 2001. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J. Biol. Chem. 276: 37250-37257.
24. Kimes, B.W. and Brandt, B.L. 1976. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp. Cell. Res. 98: 349-366.
25. Ladd, A.N. and Cooper, T.A. 2002. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3: reviews0008.
26. Ladd, A.N., Charlet, B., and Cooper, T.A. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21: 1285-1296.
27. Le Guiner, C., Gesnel, M.C., and Breathnach, R. 2003. TIA-1 or TIAR is required for DT40 cell viability. J. Biol. Chem. 278: 10465-10476.
28. Lee, K.A., Bindereif, A., and Green, M.R. 1988. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5: 22-31.
29. Lou, H., Helfman, D.M., Gagel, R.F., and Berget, S.M. 1999. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol. Cell Biol. 19: 78-85.
30. McCutcheon, I.E., Hentschel, S.J., Fuller, G.N., Jin, W., and Cote, G.J. 2004. Expression of the splicing regulator polypyrimidine tractbinding protein in normal and neoplastic brain. Neuro-oncol. 6: 9-14.
31. Modrek, B. and Lee, C. 2002. A genomic view of alternative splicing. Nat. Genet. 30: 13-19.
32. Nabeshima, Y., Nabeshima, Y., Nonomura, Y., and Fujii-Kuriyama, Y. 1987. Nonmuscle and smooth muscle myosin light chain mRNAs are generated from a single gene by the tissue-specific alternative RNA splicing. J. Biol. Chem. 262: 10608-10612.
33. Ogut, O. and Brozovich, F.V. 2000. Determinants of the contractile properties in the embryonic chicken gizzard and aorta. Am. J. Physiol. Cell. Physiol. 279: C1722-C1732.
34. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84: 767-801.
35. Payne, M.C., Zhang, H.Y., Shirasawa, Y., Koga, Y., Ikebe, M., Benoit, J.N., and Fisher, S.A. 2004. Dynamic changes in expression of myosin phosphatase in a model of portal hypertension. Am. J. Physiol. Heart Circ. Physiol. 286: H1801-H1810.
36. Payne, M.C., Joyce, K.M., Prosdocimo, D., Koga, Y., Ikebe, M., and Fisher, S.A. 2005. Myosin phosphatase isoform switching in vascular smooth muscle development. J. Mol. Cell. Cardiol. (in press).
37. Perez, I., Lin, C.H., McAfee, J.G., and Patton, J.G. 1997. Mutation of PTB binding sites causes misregulation of alternative 3′ splice site selection in vivo. RNA 3: 764.
38. Piecyk, M., Wax, S., Beck, A.R., Kedersha, N., Gupta, M., Maritim, B., Chen, S., Gueydan, C., Kruys, V., Streuli, M., et al. 2000. TIA-1 is a translational silencer that selectively regulates the expression of TNF-α. EMBO J 19: 4154-4163.
39. Polydorides, A.D., Okano, H.J., Yang, Y.Y., Stefani, G., and Darnell, R.B. 2000. A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing. Proc. Natl. Acad. Sci. 97: 6350-6355.
40. Rahman, L., Bliskovski, V., Reinhold, W., and Zajac-Kaye, M. 2002. Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles. Genomics 80: 245-249.
41. Samaha, F.F., Ip, H.S., Morrisey, E.E., Seltzer, J., Tang, Z., Solway, J., and Parmacek, M.S. 1996. Developmental pattern of expression and genomic organization of the calponin-h1 gene: A contractile smooth muscle cell marker. J. Biol. Chem. 271: 395-403.
42. Schmucker, D., Clemens, J.C., Shu, H., Worby, C.A., Xiao, J., Muda, M., Dixon, J.E., and Zipursky, S.L. 2000. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101: 671-684.
43. Shen, H., Kan, J.L, Ghigna, C., Biamonti, G., and Green, M.R. 2004. A single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2. RNA 10: 787-794.
44. Shimizu, H., Ito, M., Miyahara, M., Ichikawa, K., Okubo, S., Konishi, T., Naka, M., Tanaka, T., Hirano, K., Hartshorne, D.J., et al. 1994. Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. J. Biol. Chem. 269: 30407-30411.
45. Shukla, S., Dirksen, W.P., Joyce, K.M., Guiner-Blanvillain, C., Breathnach, R., and Fisher, S.A. 2004. TIA proteins are necessary but not sufficient for the tissue-specific splicing of the myosin phosphatase targeting subunit 1. J. Biol. Chem. 279: 13668-13676.
46. Smith, C.W. and Valcarcel, J. 2000. Alternative pre-mRNA splicing: The logic of combinatorial control. Trends Biochem. Sci. 25: 381-388.
47. Smith, R.L., Traul, D.L., Schaack, J., Clayton, G.H., Staley, K.J., and Wilcox, C.L. 2000. Characterization of promoter function and celltype -specific expression from viral vectors in the nervous system. J. Virol. 74: 11254-11261.
48. Sobue, K., Hayashi, K., and Nishida, W. 1999. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol. Cell Biochem. 190: 105-118.
49. Somlyo, A.V. and Somlyo, A.P. 1968. Electromechanical and pharmacomechanical coupling in vascular smooth muscle. J. Pharmacol. Exp. Ther. 159: 129-145.
50. Taupin, J.L., Tian, Q., Kedersha, N., Robertson, M., and Anderson, P. 1995. The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc. Natl. Acad. Sci. 92: 1629-1633.
51. Tian, Q., Streuli, M., Saito, H., Schlossman, S.F., and Anderson, P. 1991. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67: 629-639.
52. Ueki, N., Sobue, K., Kanda, K., Hada, T., and Higashino, K. 1987. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc. Natl. Acad. Sci. 84: 9049-9053.
53. Valcarcel, J. and Gebauer, F. 1997. Post-transcriptional regulation: The dawn of PTB. Curr. Biol. 7: R705-R708.
54. Wagner, E.J. and Garcia-Blanco, M.A. 2001. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21: 3281.
55. _. 2002. RNAi-mediated PTB depletion leads to enhanced exon definition. Mol. Cell 10: 943-949.
56. Wieczorek, D.F., Smith, C.W., and Nadal-Ginard, B. 1988. The rat atropomyosin gene generates a minimum of six different mRNAs coding for striated, smooth, and nonmuscle isoforms by alternative splicing. Mol. Cell Biol. 8: 679-694.
57. Wollerton, M.C., Gooding, C., Robinson, F., Brown, E.C., Jackson, R.J., and Smith, C.W. 2001. Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB). RNA 7: 819-832.
58. Zuccato, E., Buratti, E., Stuani, C., Baralle, F.E., and Pagani, F. 2004. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J. Biol. Chem. 279: 16980-16988.